Target drug delivery system as a new scarring modulation after glaucoma filtration surgery

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Shao, Tingting ^a   Li, Xiaoning ^b   Ge, Jian ^b  

^a FUDAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; DRUG CARRIER; FIBRINOLYTIC AGENT; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOMYCIN; NANOPARTICLE;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FIBROSIS; FILTERING OPERATION; HUMAN; METHODOLOGY; POSTOPERATIVE COMPLICATION; SCAR; WOUND HEALING;

CHITOSAN; CICATRIX; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; FIBROSIS; FILTERING SURGERY; HUMANS; HYALURONIC ACID; MITOMYCIN; NANOPARTICLES; POSTOPERATIVE COMPLICATIONS; RECEPTORS, LDL; WOUND HEALING;

EID: 79959982369     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-64     Document Type: Article

References (27)

1. Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF. Modulation of wound healing after glaucoma surgery. Current opinion in ophthalmology 2001, 12:143-148. 10.1097/00055735-200104000-00011, 11224722.
2. Chang L, Crowston JG, Cordeiro MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Survey of ophthalmology 2000, 45:49-68. 10.1016/S0039-6257(00)00135-1, 10946081.
3. Mearza AA, Aslanides IM. Uses and complications of mitomycin C in ophthalmology. Expert opinion on drug safety 2007, 6:27-32. 10.1517/14740338.6.1.27, 17181449.
4. Wong TT, Mead AL, Khaw PT. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Investigative ophthalmology & visual science 2005, 46:2018-2022. 10.1167/iovs.04-0820, 21609224.
5. Kanamoto T, Souchelnytskyi N, Kiuchi Y. Functional proteomics of failed filtering blebs. Molecular vision 2009, 15:2762-2770. 2793902, 20019882.
6. Memarzadeh F, Varma R, Lin LT, Parikh JG, Dustin L, Alcaraz A, Eliott D. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Investigative ophthalmology & visual science 2009, 50:3233-3237. 10.1167/iovs.08-2441, 21609224.
7. Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Progress in brain research 2008, 173:237-254.
8. Shigeeda T, Tomidokoro A, Chen YN, Shirato S, Araie M. Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. Journal of glaucoma 2006, 15:195-199. 10.1097/01.ijg.0000212202.57029.45, 16778640.
9. Mansouri K, Ravinet E. Effect of different application depths of mitomycin-C in deep sclerectomy with collagen implant: a randomized controlled trial. Clinical & experimental ophthalmology 2009, 37:286-292. 10.1111/j.1442-9071.2009.02030.x, 21739672.
10. Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs 2006, 66:321-340. 10.2165/00003495-200666030-00005, 16526821.
11. Hsu WC, Ritch R, Krupin T, Chen HS. Tissue bioengineering for surgical bleb defects: an animal study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2008, 246:709-717.
12. Blake DA, Sahiner N, John VT, Clinton AD, Galler KE, Walsh M, Arosemena A, Johnson PY, Ayyala RS. Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels. Journal of glaucoma 2006, 15:291-298. 10.1097/01.ijg.0000212236.96039.9c, 16865005.
13. Zimmerman C, Drewe J, Flammer J, Shaarawy T. In vitro release of mitomycin C from collagen implants. Current eye research 2004, 28:1-4. 10.1076/ceyr.28.1.1.23492, 14704907.
14. Adjadj E, Roy S, Zimmermann C, Shaarawy T, Flammer J, Mermoud A, Drewe J. Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye. Journal francais d'ophtalmologie 2006, 29:1042-1046. 10.1016/S0181-5512(06)73893-1, 21658048.
15. Jin S, Ye K. Nanoparticle-mediated drug delivery and gene therapy. Biotechnology progress 2007, 23:32-41. 10.1021/bp060348j, 17269667.
16. Broz P, Benito SM, Saw C, Burger P, Heider H, Pfisterer M, Marsch S, Meier W, Hunziker P. Cell targeting by a generic receptor-targeted polymer nanocontainer platform. J Control Release 2005, 102:475-488. 10.1016/j.jconrel.2004.10.014, 15653165.
17. Chen HY, Ge J, Guo Y, Jin CJ, Lan YQ, Lin MK. The inhibition effect of photodynamic on human Tenon capsule fibroblast cells. Chinese journal of ophthalmology 2003, 39:160-162.
18. Jordan JF, Diestelhorst M, Grisanti S, Krieglstein GK. Photodynamic modulation of wound healing in glaucoma filtration surgery. The British journal of ophthalmology 2003, 87:870-875. 10.1136/bjo.87.7.870, 1771734, 12812889.
19. Li H, Gray BD, Corbin I, Lebherz C, Choi H, Lund-Katz S, Wilson JM, Glickson JD, Zhou R. MR and fluorescent imaging of low-density lipoprotein receptors. Academic radiology 2004, 11:1251-1259. 10.1016/j.acra.2004.08.007, 15561572.
20. Konan YN, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. Journal of photochemistry and photobiology 2002, 66:89-106.
21. Nikanjam M, Blakely EA, Bjornstad KA, Shu X, Budinger TF, Forte TM. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. International journal of pharmaceutics 2007, 328:86-94. 10.1016/j.ijpharm.2006.07.046, 16959446.
22. Shao T, Gao Q, Jiang R, Duan Y, Sun X, Ge J. Dynamic alteration of low-density lipoprotein receptor after exposure to transforming growth factor-beta2 in human Tenon's capsule fibroblasts. J Ocul Pharmacol Ther 2009, 25:499-506. 10.1089/jop.2009.0042, 20028258.
23. Song Y, Onishi H, Nagai T. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin. Chemical & pharmaceutical bulletin 1992, 40:2822-2825.
24. Kato Y, Onishi H, Machida Y. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates. Biomaterials 2004, 25:907-915. 10.1016/S0142-9612(03)00598-2, 14609679.
25. Li H, Marotta DE, Kim S, Busch TM, Wileyto EP, Zheng G. High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. Journal of biomedical optics 2005, 10:41203. 10.1117/1.2011429, 16178627.
26. Duan L, Zheng Q, Li X, Quan D, Ge J. Synthesisi and controlled release of a chitosan-based polymeric prodrug of mitomycin C [abstract]. Symposium on innovative polymers for controlled delivery 2010, 99-101.
27. Takeuchi K, Nakazawa M, Yamazaki H, Miyagawa Y, Ito T, Ishikawa F, Metoki T. Solid hyaluronic acid film and the prevention of postoperative fibrous scar formation in experimental animal eyes. Archives of ophthalmology 2009, 127:460-464. 10.1001/archophthalmol.2009.70, 19365025.